alzheimer’s

Link: https://www.cnn.com/2023/06/09/health/fda-committee-lecanemab-leqembi/index.html The recent FDA advisory committee’s recommendation* to approve Lecanemab (Leqembi) for the treatment of memory loss associated with Alzheimer’s disease highlights the vital role of clinical research in advancing breakthrough treatments. Clinical research is crucial in understanding the complexities of memory loss conditions, identifying potential therapies, and determining their safety and efficacy.   …

Read more

Alzheimer’s disease is a topic that has captured the attention of scientists, researchers, and medical professionals for decades. With its devastating impact on memory, cognition, and overall quality of life, Alzheimer’s poses significant challenges to individuals and their loved ones. In this blog post, we embark on a journey to explore the intricacies of this …

Read more

Alzheimer’s disease (AD) was first described in 1906. Since then, numerous breakthroughs in technology, infrastructure, and disease knowledge have helped improve patients’ lives and push us closer to a cure. Though the road is still very long ahead of us, November marks a time to pause and reflect on past, present, and future efforts. These …

Read more